Roberto Saenz II, OD
Optometrists (Corneal and Contact Management Optometrist)
- Medicare participating
At a glance
- Medical school
- University of Houston - College of Optometry (2016)
- Years since graduation
- 10
- In the NPI registry since
- 2016
- Medicare patients seen, 2024
- 187
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2016Medical school: University of Houston - College of Optometry
- 2016Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Corneal and Contact Management Optometrist primary
TX license 9029TG · TX license 9029T -
Ophthalmology Physician
TX license 9029TG -
Optometrist
TX license 9029TG
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Mission Cataract and Lasik (4 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 187
- Services billed
- 643
- Patients’ average age
- 73
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 10 companies reported 31 payments worth $14,274 in total to this clinician.
| Sight Sciences, Inc. | $8,263 |
|---|---|
| Glaukos Corporation | $3,702 |
| AbbVie Inc. | $910 |
| Rxsight Inc | $883 |
| Harrow Eye, LLC | $150 |
| Bausch & Lomb Americas Inc. | $117 |
| Johnson & Johnson Surgical Vision, Inc. | $116 |
| Carl Zeiss Meditec USA, Inc. | $66.88 |
| Compensation for services other than consulting (speaking, faculty) | $8,250 |
|---|---|
| Consulting Fee | $5,125 |
| Food and Beverage | $866 |
| Honoraria | $32.81 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Sight Sciences, Inc. Jan 16, 2025 | Compensation for services other than consulting (speaking, faculty) TEARCARE SYSTEM · Ophthalmology | $3,850 |
| Sight Sciences, Inc. Mar 20, 2025 | Compensation for services other than consulting (speaking, faculty) TEARCARE SYSTEM · Ophthalmology | $3,850 |
| Glaukos Corporation Nov 26, 2025 | Consulting Fee KXL System · Ophthalmology | $2,820 |
| Glaukos Corporation Jan 8, 2025 | Consulting Fee KXL System · Ophthalmology | $705 |
| Sight Sciences, Inc. Dec 5, 2025 | Compensation for services other than consulting (speaking, faculty) TEARCARE SYSTEM · Ophthalmology | $550 |
| Rxsight Inc Mar 28, 2025 | Consulting Fee RXSIGHT CONTACT LENS; RXSIGHT INJECTOR CARTRIDGE; RXSIGHT LIGHT DELIVERY DEVICE (LDD) · OPHTHALMOLOGY | $500 |
| AbbVie Inc. Jan 6, 2025 | Consulting Fee | $425 |
| AbbVie Inc. Feb 13, 2025 | Consulting Fee | $425 |
| Rxsight Inc Apr 11, 2025 | Consulting Fee RXSIGHT CONTACT LENS; RXSIGHT INJECTOR CARTRIDGE; RXSIGHT LIGHT DELIVERY DEVICE (LDD) · OPHTHALMOLOGY | $250 |
| Rxsight Inc Feb 3, 2025 | Honoraria RXSIGHT CONTACT LENS; RXSIGHT INJECTOR CARTRIDGE; LIGHT ADJUSTABLE LENS (LAL) · OPHTHALMOLOGY · in-kind | $32.81 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $16,246 in research payments for these studies, mostly to the institutions running them.
- Safety And Effectiveness Of The TearCare® System In The Treatment Of The Signs And Symptoms Of Dry Eye Disease (SAHARA)
Sight Sciences, Inc. · Completed · NCT04795752
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.